December 12, 2017 10:28 PM ET

Pharmaceuticals

Company Overview of Survac ApS

Company Overview

Survac ApS focuses on the development of peptide based therapeutic cancer vaccines. It intends to offer the vaccine candidates for licensing and collaboration agreements. The company’s vaccine is being examined in clinical phase I/II trials. Survac ApS was founded in 2003 and is based in Hellerup, Denmark. As of January 6, 2006, Survac ApS operates as a subsidiary of Merck Group.

Esthersvej 27

Hellerup,  2900

Denmark

Founded in 2003

Key Executives for Survac ApS

Administrative Director
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
7TM Pharma A/S Europe
Acesion Pharma ApS Europe
Action Pharma A/S Europe
Adenium Biotech ApS Europe
Alkalon A/S Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Survac ApS, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.